BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2764640)

  • 1. Idebenone improves learning and memory impairment induced by cholinergic or serotonergic dysfunction in rats.
    Yamazaki N; Nomura M; Nagaoka A; Nagawa Y
    Arch Gerontol Geriatr; 1989 May; 8(3):225-39. PubMed ID: 2764640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of idebenone on scopolamine-induced impairment of short-term memory in rats].
    Yamazaki N; Nagaoka A; Nagawa Y
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):321-8. PubMed ID: 3832686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of idebenone (CV-2619) on brightness discrimination learning in rats with central serotonergic dysfunction].
    Nomura M
    Yakubutsu Seishin Kodo; 1985 Sep; 5(3):243-9. PubMed ID: 4072435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of idebenone on memory impairment induced in ischemic and embolization models of cerebrovascular disturbance in rats.
    Yamazaki N; Kiyota Y; Take Y; Miyamoto M; Nagawa Y; Nagaoka A
    Arch Gerontol Geriatr; 1989 May; 8(3):213-24. PubMed ID: 2764639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ameliorating effects of idebenone and indeloxazine hydrochloride on impairment of radial maze learning in cerebral embolized rats].
    Kiyota Y; Miyamoto M; Nagaoka A
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):197-202. PubMed ID: 2731809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of idebenone (CV-2619) on memory impairment observed in passive avoidance task in rats with cerebral embolization.
    Kiyota Y; Hamajo K; Miyamoto M; Nagaoka A
    Jpn J Pharmacol; 1985 Mar; 37(3):300-2. PubMed ID: 3999479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on scopolamine-induced impairment of short-term memory in rats].
    Yamazaki N; Nagaoka A; Nagawa Y
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):359-66. PubMed ID: 3101313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer.
    Ogasawara T; Itoh Y; Tamura M; Mushiroi T; Ukai Y; Kise M; Kimura K
    Pharmacol Biochem Behav; 1999 Sep; 64(1):41-52. PubMed ID: 10494996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
    Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.
    Yamamoto T; Yatsugi S; Ohno M; Furuya Y; Kitajima I; Ueki S
    Psychopharmacology (Berl); 1990; 100(3):316-22. PubMed ID: 2315427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thymoquinone on scopolamine-induced spatial and echoic memory changes through regulation of lipid peroxidation and cholinergic impairment.
    Kantar D; Acun AD; Danışman B
    Behav Brain Res; 2022 Aug; 431():113972. PubMed ID: 35718231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-amnesic effect of extract and alkaloid fraction from aerial parts of Peganum harmala on scopolamine-induced memory deficits in mice.
    Liu W; Zhu Y; Wang Y; Qi S; Wang Y; Ma C; Li S; Jiang B; Cheng X; Wang Z; Xuan Z; Wang C
    J Ethnopharmacol; 2017 May; 204():95-106. PubMed ID: 28442406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat.
    Lieben CK; Blokland A; Sik A; Sung E; van Nieuwenhuizen P; Schreiber R
    Neuropsychopharmacology; 2005 Dec; 30(12):2169-79. PubMed ID: 15957009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
    Hiramatsu M; Inoue K
    Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats.
    Beninger RJ; Wirsching BA; Mallet PE; Jhamandas K; Boegman RJ
    Pharmacol Biochem Behav; 1995 Aug; 51(4):739-46. PubMed ID: 7675853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the dorsal raphe-serotonergic system and cholinergic receptors in the modulation of working memory.
    Ruotsalainen S; Miettinen R; MacDonald E; Riekkinen M; Sirviö J
    Neurosci Biobehav Rev; 1998; 22(1):21-31. PubMed ID: 9491938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholinergic activation by physostigmine on working memory failure caused in rats by pharmacological manipulation of hippocampal glutamatergic and 5-HTergic neurotransmission.
    Ohno M; Kishi A; Watanabe S
    Neurosci Lett; 1996 Oct; 217(1):21-4. PubMed ID: 8905730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice.
    Ukai M; Katoh T; Mamiya T
    Neuroreport; 2001 Dec; 12(17):3723-7. PubMed ID: 11726782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholinergic drugs and cerebral metabolic activators on memory impairment in old rats.
    Kamei C; Tsujimoto S; Tasaka K
    J Pharmacobiodyn; 1990 Dec; 13(12):772-7. PubMed ID: 2098550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.